Trials / Completed
CompletedNCT02879955
Carbohydrates and Gut Hormones After Gastric Bypass Surgery
Effects of Carbohydrates on Gut Hormone Secretion After Gastric Bypass Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To investigate the secretion of gut hormones, in particular glucagon-like peptide 1 (GLP-1), after ingestion of glucose and fructose as separate monosaccharides or combined in the disaccharides sucrose and isomaltulose and the effect of acarbose in gastric bypass operated subjects and BMI-matched controls.
Detailed description
Disaccharides such as sucrose or isomaltulose (also called palatinose) require digestion into monosaccharides (both are digested to glucose and fructose) by enzymes located in the brush border of the small intestine to be absorbed. The study will investigate the influence of carbohydrate digestion on gut hormone secretion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucose + Fructose | Ingestion of the separate monosaccharides glucose (25 g) and fructose (25 g) dissolved in 200 mL of water. The load provides 0.1385 mol glucose and 0.1385 mol fructose. |
| OTHER | Sucrose | Ingestion of the disaccharide sucrose (47.5 g) dissolved in 200 mL of water. The load provides 0.1385 mol glucose and 0.1385 mol fructose. |
| OTHER | Isomaltulose | Ingestion of the slowly digestable disaccharide isomaltulose (47.5 g) dissolved in 200 mL of water. The load provides 0.1385 mol glucose and 0.1385 mol fructose. |
| OTHER | Sucrose + Acarbose | Ingestion of the disaccharide sucrose (47.5 g) and the alpha glucosidase inhibitor acarbose dissolved in 200 mL of water. The load provides 0.1385 mol glucose and 0.1385 mol fructose. |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-08-26
- Last updated
- 2017-07-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02879955. Inclusion in this directory is not an endorsement.